trending Market Intelligence /marketintelligence/en/news-insights/trending/ndaqdbe7od2zv8fyxw1jza2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Eagle Pharmaceuticals names president

L.K. Bennett: Bankruptcy Case Study

State Of Singapore Online Video Subscription

Power Forecast Briefing: Capacity Shortfalls to Test the Renewable Energy Transition

Episode 43 - More Change, M&A On Horizon For Equity Research Industry


Eagle Pharmaceuticals names president

Eagle Pharmaceuticals Inc. appointed David Pernock president and chief commercial officer, effective January 2017.

Pernock, who will report to CEO Scott Tarriff, will oversee all commercial strategy and execution for Eagle's product portfolio.

Pernock most recently was the CEO of gene therapy biotechnology company Fibrocell Science and previously was GlaxoSmithKline plc's senior vice president of pharmaceuticals, vaccines, oncology, acute care and HIV divisions.

Pernock has been serving Eagle Pharmaceuticals as a director since April 2015. He will give up this position when his new role takes effect.